Superficial radiotherapy as haemostatic treatment in breast cancer
Resumen: Poster Session [EP-1661]
Purpose or Objective Breast cancer is a common pathology in which <10% of cases at the moment of diagnosis are considered to be locally advanced. In patients with locally advanced breast cancer who have deterioration in overall condition, with local growth and secondary bl eeding that are not subsidiary to surgery or other systemic therapies, superficial radiotherapy may be considered as an option in the treatment of these patients Objectives: It is described a number of cases with patients with locally advanced breast cance r with secondary bleeding who were treated with superficial radiotherapy for haemostatic purposes Material and Methods For a period from May 2016 to August 2017, 6 patients with locally advanced breast cancer who did not respond to systemic treatment or d ue to the disease or comorbidities associated were not candidates for that, who presented tumour growth with secondary bleeding and they were not subsidiaries of surgery. Superficial radiotherapy were administrated by a low energy X -Ray machine, with a tot al dose of 50 - 60Gy, divided in 1 -2 fractions per week. The haemostatic effect was value at the end of treatment. Results The average age was 73 years, most patients presented a grade 2 functional status (ECOG2). At the end of treatment, was objected a decrease of > o = 25% in tumor size and absence of bleeding was observed. Conclusion Surface radiotherapy is a treatment modality that should be taken into account in patients with breast cancer who present bleeding as a consequence of local tumor growth, given that this is a treatment comfortable for the patient, non invasive and increases the quality of patient’s life.

Idioma: Inglés
DOI: 10.1016/S0167-8140(18)31970-4
Año: 2018
Publicado en: RADIOTHERAPY AND ONCOLOGY 127, Suppl. 1 (2018), S893
ISSN: 0167-8140

Factor impacto JCR: 5.252 (2018)
Categ. JCR: RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING rank: 14 / 129 = 0.109 (2018) - Q1 - T1
Categ. JCR: ONCOLOGY rank: 46 / 229 = 0.201 (2018) - Q1 - T1

Factor impacto SCIMAGO: 2.023 - Hematology (Q1) - Radiology, Nuclear Medicine and Imaging (Q1) - Oncology (Q1)

Tipo y forma: Comunicación congreso (Versión definitiva)
Área (Departamento): Área Radiol. y Medicina Física (Dpto. Pediatría Radiol.Med.Fís)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.


Exportado de SIDERAL (2020-01-17-22:10:22)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos



 Registro creado el 2018-10-18, última modificación el 2020-01-17


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)